Chronic invasive aspergillosis with fulminant mucormycosis sparing palate in a Post-COVID-19 patient - A case report

5Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Rationale: COVID-19 patients, especially immunocompromised or severely ill, have a higher probability of suffering from invasive fungal infections. Patient Concerns: A 41-years-old male reported with pain and heaviness in the face for the past 20 days. Patient had tested COVID-19 positive 20 days back and was recently diagnosed with diabetes mellitus. On histopathological examination numerous hyphae resembling mucor and asper fungi were evident. Diagnosis: Chronic invasive aspergillosis with fulminant mucormycosis sparing palate. Treatment: Since the lesion was spreading very rapidly the patient was referred to an isolation facility for further management. Outcomes: We have postulated few hypothesis for the coinfection of aspergillosis and mucormycosis in our patient. Take-away Lessons: It is important for the clinicians to systematically screen post COVID-19 patients for fungal infections, especially in immunocompromised and severely ill patients.

Cite

CITATION STYLE

APA

Ramani, P., Krishnan, R. P., Pandiar, D., Benitha, J. G., Ramalingam, K., & Gheena, S. (2022). Chronic invasive aspergillosis with fulminant mucormycosis sparing palate in a Post-COVID-19 patient - A case report. Annals of Maxillofacial Surgery, 12(1), 102–105. https://doi.org/10.4103/ams.ams_296_21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free